Skip to main content
AAPS Open
Fig. 2 | AAPS Open

Fig. 2

From: Formulation mitigations for particle formation induced by enzymatic hydrolysis of polysorbate 20 in protein-based drug products: insights from a full-factorial longitudinal study

Fig. 2

Storage duration without VPs observed for mAb X DP as a function of [mAb]. The 24 formulations (listed in Table 1) represent unique combinations of [mAb], initial [PS20], and pH. At the end of the DP stability study (24 weeks at 5 °C), only one formulation (F24 as shown in Table 1) remained free from VPs

Back to article page